GLP1R and type 2 diabetes mellitus: Moreover, the observed high incidence of MACEs, which reached 12.0% in the non-users during follow-up, highlights the elevated cardiovascular risk among KTRs with T2DM, underscoring the importance of incorporating GLP-1 RAs into the DM care for these specific population.